Luminous Efficiency Function V(λ)' of Patients That Underwent Pseudophakic Presbyopic Corrections… (NCT07077967) | Clinical Trial Compass
RecruitingNot Applicable
Luminous Efficiency Function V(λ)' of Patients That Underwent Pseudophakic Presbyopic Corrections With EDOF IOLs
Greece100 participantsStarted 2025-10-15
Plain-language summary
Primary objective of this study is to introduce a modified luminous efficiency function that addresses the distinct total eye light transmittance of patients who underwent pseudophakic presbyopic correction with extended-depth of focus (EDOF) intraocular lenses (IOLs) implantations.
Who can participate
Age range
45 Years – 75 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* age between 45 to 75 years
Exclusion Criteria:
* astigmatism \>1.00 diopters
* glaucoma
* former incisional eye surgery
* corneal or fundus disease
* diabetes mellitus
* autoimmune diseases
* neurological or psychiatric diseases
* posterior capsule rupture or lens misalignment
* postoperative uncorrected distance visual acuity \< 8/10.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial is measuring something called 'Minimum Required Illuminance Level' — can you explain what that means in everyday terms and how it relates to how well I'd see after getting an EDOF lens implant?
2Since this study is listed as Phase NA, which often means it's more of an observational or measurement study rather than a treatment trial, can you help me understand whether joining would change my actual treatment plan or just involve extra testing and measurements?
3The trial involves pseudophakic presbyopia correction with EDOF lenses — is this type of lens something you'd already consider for me, and would participating in this study affect which specific lens I'd receive?
4I've heard EDOF lenses work differently than standard monofocal lenses for presbyopia — based on what this study is measuring about light sensitivity, are there any vision quality trade-offs I should understand before deciding whether this approach is right for me?
5Since the trial is actively recruiting, what would my time commitment look like — how many visits would I need, what kinds of measurements would be taken, and would any of this be inconvenient or difficult depending on where I live or work?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.